vardenafil
CHEBI:CHEBI_46295
Definition
The sulfonamide resulting from formal condensation of the sulfo group of 4-ethoxy-3-(5-methyl-7-propylimidazo[5,1-f][1,2,4]triazin-4(1H)-one-2-yl)benzenesulfonic acid and the secondary amino group of 4-ethylpiperazine.
Chemical Information
- Molecular Formula
- C23H32N6O4S
- Molecular Mass
- 488.60300
- Charge
- 0
- SMILES
- CCCc1nc(C)c2n1[nH]c(nc2=O)-c1cc(ccc1OCC)S(=O)(=O)N1CCN(CC)CC1
- InChI
- InChI=1S/C23H32N6O4S/c1-5-8-20-24-16(4)21-23(30)25-22(26-29(20)21)18-15-17(9-10-19(18)33-7-3)34(31,32)28-13-11-27(6-2)12-14-28/h9-10,15H,5-8,11-14H2,1-4H3,(H,25,26,30)
- InChIKey
- SECKRCOLJRRGGV-UHFFFAOYSA-N
Alternative Names
- 2-{2-ethoxy-5-[(4-ethylpiperazin-1-yl)sulfonyl]phenyl}-5-methyl-7-propylimidazo[5,1-f][1,2,4]triazin-4(1H)-one
- 2-{2-ETHOXY-5-[(4-ETHYLPIPERAZIN-1-YL)SULFONYL]PHENYL}-5-METHYL-7-PROPYLIMIDAZO[5,1-F][1,2,4]TRIAZIN-4(1H)-ONE
- Levitra
Drug Classification
-
N-alkylpiperazineView Class →
CHEBI:46845
-
imidazotriazineView Class →
CHEBI:46906
-
N-sulfonylpiperazineView Class →
CHEBI:46918
-
t221031
-
t221077
Important Medical Information
⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.
- Always consult with a healthcare professional before starting, stopping, or modifying any medication.
- Side effects may vary and this list may not be comprehensive.
- Drug interactions may occur with other medications.
Additional Identifiers
- DRON_00010000
- 306674
- oboInOwl#hasDbXref
- Wikipedia:Vardenafil
- core#notation
- CHEBI:46295
Additional References
🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.
Additional Attributes
- product_type
- BULK INGREDIENT
- listing_expiration_date
- 20241231
- route
- ORAL
- dosage_form
- TABLET, ORALLY DISINTEGRATING
- marketing_category
- BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
- labeler_name
- Vardenafil Hydrochloride Trihydrate
- marketing_start_date
- 20030819
- application_number
- ANDA208324
- spl_id
- fa93416c-7ce5-44f2-8b35-1abba47a34a6
- package_ndc
- 12658-0463-1
- product_ndc
- 71052-642
- package_marketing_start_date
- 18-JUN-19
- package_description
- 100 TABLET, FILM COATED in 1 BOTTLE (46708-239-31)
- has_treatment
- http://purl.obolibrary.org/obo/DOID_4762
- rdf-schema#domain
- https://w3id.org/def/predibionto#has_side_effect24721
- owl#annotatedSource
- t221509
- owl#someValuesFrom
- t3000899
- oboInOwl#hasOBONamespace
- chebi_ontology
- DRON_00010000
- 306674
- oboInOwl#hasDbXref
- Wikipedia:Vardenafil
- oboInOwl#id
- CHEBI:46295
- generic_name
- Vardenafil HCl Trihydrate
- brand_name
- VARDENAFIL
- brand_name_base
- VARDENAFIL
- RO_0000087
- http://purl.obolibrary.org/obo/CHEBI_50218
- oboInOwl#inSubset
- http://purl.obolibrary.org/obo/chebi#3_STAR
- core#notation
- CHEBI:46295
- rxcui
- 996179
- active_ingredient_strength
- .5 kg/.5kg
- pharm_class_epc
- Phosphodiesterase 5 Inhibitor [EPC]
- pharm_class
- Phosphodiesterase 5 Inhibitors [MoA]
- pharm_class_moa
- Phosphodiesterase 5 Inhibitors [MoA]
- manufacturer_name
- Zydus Pharmaceuticals USA Inc.
- nui
- N0000020026
- active_ingredient_name
- VARDENAFIL
- unii
- UCE6F4125H
- spl_set_id
- 57a0c163-a5e8-4c6e-a4ea-114cb2668407
- upc
- 0362135864309
- 22-rdf-syntax-ns#type
- http://www.w3.org/2002/07/owl#Class